Research Article

Seasonal Monitoring of Cardiovascular and Antiulcer Agents’ Concentrations in Stream Waters Encompassing a Capital City

Table 2

Compound-specific LC-MS/MS parameters of the investigated compounds.

Compounds TSFragVMRM1CE1MRM2CE2MRM ratio

Acebutolol6.037270337.1 > 11625337.1 > 2182516.0
Amlodipine6.9462100409.1 > 23810409.1 > 294.11055.4
Atenolol1.6291130267.1 > 144.925267.1 > 1902045.6
Atenolol-d71.6121120274.2 > 14525274.2 > 79.120109.3
Atorvastatin8.0822120559.4 > 440.320559.4 > 466.21514.8
Betaxolol6.711270308.1 > 116.120308.1 > 1612023.9
Carvedilol6.8802150407.1 > 224.125407.1 > 2832081.8
Cimetidine1.597190253.1 > 9530253.1 > 1591090.7
Cimetidine-d31.598170256.1 > 162.110256.1 > 95.12588.4
Enalapril6.6502140377.2 > 234.215377.2 > 303.21528.4
Enalapril-d56.6372120382.2 > 239.115382.2 > 308.21539.4
Esmolol6.2652100296.1 > 21915296.1 > 254.11526.8
Famotidine1.551160338.1 > 18915338.1 > 1553052.9
Fluvastatin8.1002130412.2 > 22430412.2 > 266.11585.3
Lansoprazole7.118280370.1 > 252.110370.1 > 119.11530.0
Lansoprazole-d47.107290374.1 > 2525374.1 > 1232036.7
Lisinopril3.0511110406.3 > 84.130406.3 > 246.22024.8
Lovastatin9.729250405.3 > 199.110405.3 > 285.1590.7
Metoprolol6.1192140268.2 > 116.115268.2 > 74.12093.8
Nifedipine7.712270347.1 > 315.10347.1 > 254.11556.3
Nimodipine8.466270419.2 > 343.15419.2 > 301.12556.6
Nizatidine1.8961100332.1 > 58.130332.1 > 1551540.9
Omeprazole6.6802100346.1 > 19810346.1 > 136.13046.7
Oxprenolol6.3912110266.1 > 72.215266.1 > 116.21531.5
Pantoprazole6.8992110384.2 > 200.110384.2 > 138.13091.6
Propanolol6.588290260.1 > 116.215260.1 > 183.21571.6
Ramipril7.1392120417.3 > 234.225417.3 > 130.12522.3
Ranitidine2.374190315.2 > 176.115315.2 > 130.12560.9
Simvastatin9.746280419.3 > 199.25419.3 > 285.2589.3
Sotalol1.7481100273.1 > 2555273.1 > 1333060.8

: retention time (min); TS: time segment; FragV: Fragmentor voltage (V); MRM1: quantifier transition; CE1: collision energy for MRM1 (V); MRM2: qualifier transition; CE2: collision energy for MRM2 (V); MRM ratio: ratio of the two MRMs.